share_log

HC Wainwright & Co. Maintains Buy on Compass Therapeutics, Maintains $10 Price Target

HC Wainwright & Co. Maintains Buy on Compass Therapeutics, Maintains $10 Price Target

HC Wainwright & Co. 維持對Compass Therapeutics的買入評級,維持10美元的目標價格
Benzinga ·  01/08 11:24  · 評級/大行評級

HC Wainwright & Co. analyst Joseph Pantginis maintains Compass Therapeutics (NASDAQ:CMPX) with a Buy and maintains $10 price target.

HC Wainwright & Co. 分析師Joseph Pantginis維持對Compass Therapeutics (納斯達克:CMPX)的買入評級,維持10美元的目標價。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論